These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 43777)

  • 1. C.R.O.S. conference on combined modalities chemotherapy/radiotherapy. Hilton Head Island, South Carolina, November 15--18, 1978.
    Carter SK
    Cancer Chemother Pharmacol; 1979; 2(2):139-42. PubMed ID: 43777
    [No Abstract]   [Full Text] [Related]  

  • 2. Conference on combined modalities: chemotherapy/radiotherapy. Hilton Head Island, South Carolina, November 15-18, 1978.
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1139-423. PubMed ID: 43303
    [No Abstract]   [Full Text] [Related]  

  • 3. Conference on Combined Modalities: Chemotherapy/Radiotherapy. Part 2. Hilton Head Island, South Carolina, November 15-18, 1978.
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1425-723. PubMed ID: 94046
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop.
    Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R
    Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: European Organization for Research on Treatment of Cancer: origin, organization, and current activities.
    van Bekkum DW
    Natl Cancer Inst Monogr; 1974 Feb; 40():83-90. PubMed ID: 4150493
    [No Abstract]   [Full Text] [Related]  

  • 6. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 7. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract]   [Full Text] [Related]  

  • 8. The national program for cancer chemotherapy.
    Zubrod CG
    JAMA; 1972 Nov; 222(9):1161-2. PubMed ID: 4678048
    [No Abstract]   [Full Text] [Related]  

  • 9. The radiation Oncology Research Program: recommended research proposals.
    Int J Radiat Oncol Biol Phys; 1979 May; 5(5):593-773. PubMed ID: 37200
    [No Abstract]   [Full Text] [Related]  

  • 10. The evaluation of cytotoxic drugs.
    Von Hoff DD; Rozencweig M; Muggia FM
    Cancer Treat Rev; 1979 Jun; 6 Suppl():1-8. PubMed ID: 498161
    [No Abstract]   [Full Text] [Related]  

  • 11. Planning combined therapy--the interaction of experimental and clinical studies.
    Carter SK
    Cancer Chemother Rep 2; 1974 Mar; 4(1):3-11. PubMed ID: 4826498
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings of the 4th Conference on Immune Modulation and Control of Neoplasia by Adjuvant Therapy. Division of Cancer Cause and Prevention, National Cancer Institute.
    Cancer Treat Rep; 1978 Nov; 62(11):1611-998. PubMed ID: 31977
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings of the NCI-EORTC symposium on new drugs in cancer therapy, Institut Jules Bordet, September 7--8, 1978 Brussels, Belgium.
    Cancer Treat Rep; 1979 May; 63(5):807-936. PubMed ID: 36983
    [No Abstract]   [Full Text] [Related]  

  • 14. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
    Carter SK; Slavik M
    Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer chemotherapy: new recruits.
    David P
    Nature; 1983 Aug 25-31; 304(5928):675. PubMed ID: 6888533
    [No Abstract]   [Full Text] [Related]  

  • 16. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis.
    Cherian MG; Huang PC; Klaassen CD; Liu YP; Longfellow DG; Waalkes MP
    Cancer Res; 1993 Feb; 53(4):922-5. PubMed ID: 8428370
    [No Abstract]   [Full Text] [Related]  

  • 17. AACR-NCI-EORTC-15th symposium molecular targets and cancer therapeutics: enzyme inhibitors and anti-angiogenics.
    Mayfield R
    IDrugs; 2004 Jan; 7(1):19-21. PubMed ID: 14968809
    [No Abstract]   [Full Text] [Related]  

  • 18. Origins and development of chemotherapy research at the National Cancer Institute.
    Zubrod CG
    Cancer Treat Rep; 1984 Jan; 68(1):9-19. PubMed ID: 6362871
    [No Abstract]   [Full Text] [Related]  

  • 19. Thoughts on cancer chemotherapy and combination modality therapy (1974).
    Skipper HE
    JAMA; 1974 Nov; 230(7):1033-5. PubMed ID: 4608173
    [No Abstract]   [Full Text] [Related]  

  • 20. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.